Funds in Focus – September 2023

Our monthly summary of market movements over the past month, what drove them, and our views ahead. We will also reveal our top fund recommendations for September 2023, alongside other interesting fund ideas worth highlighting.

Zheng Bolun
Zheng Bolun10 Oct 2023 1745 Views
Funds in Focus – September 2023

How did FSM Indices (Equities & Bonds) perform in September?

September was a difficult month for both fixed income and equity markets, with the Fed pointing towards more restrictive policy and a higher-for-longer approach to interest rates. Overall, FSM Indices – All Bond outperformed FSM Indices – All Equity, returning -1.20% and -1.82% respectively (all performance figures in SGD terms), as investors adopted a risk-off approach.

Note: FSM Indices are a simple average of all unique fund strategies within the category listed on our platform. Investors can use it to compare a single fund against its peer average, or its actively managed products on our platform against the market index


Figure 1: FSM Indices Performance in September 


FSM Indices – Asian High Yield Bond was the best performer for the month, returning positive returns of +1.88%. The relatively better performance was due to the gradual credit spread tightening, coming off an extremely bearish position. Furthermore, there was positive news flow coming from China, as Country Garden, one of China’s largest property developers, managed to dodge a default and extended its bond payments, which drove some optimism back into the markets.

FSM Indices – Global Property Equity was the worst performer for the month, with a -7.07% decline. The real estate sector is particularly sensitive to interest rates and the shift towards higher-for-longer rates have negatively affected investors’ sentiments especially when these properties need to refinanced at these higher rates in future. China’s real estate market continues to remain fragile, with poor consumer and investment sentiment impacting the demand for Chinese properties, and serving as a drag on the country’s economic growth.

FSM Indices – Technology Equity was another poor performer in the month of September, registering a -7.06% decline as 10-Year Treasury yields surged.  With investors starting to digest the Federal Reserve’s stance to keep interest rates higher-for-longer, tech stocks which  tend to be more growth-oriented have experienced a sell-down with the likes of Apple, Amazon, Nvidia down by -7.94%, -6.95%, -10.96% (in SGD terms) respectively in the month of September. 

Looking at commodity and energy funds, they delivered mixed results in September (Figure 2). Energy-related funds outperformed gold-related funds, as oil prices have been creeping up on lower US crude inventories and further output cuts by OPEC+, while higher Treasury yields make holding zero-yield bullion less attractive. 

Figure 2: Returns of Commodity and Energy Funds in September


Here are some noteworthy funds we’ll like you to check out

Manulife Asia-Pacific Investment Grade Bond Fund: A strategic way to navigate the Asian IG landscape

For investors who are looking to actively navigate the diverse Asian Investment Grade (IG) Bond landscape, the Manulife Asia Pacific Investment Grade Bond Fund is our top pick. We believe the Asian IG bond segment remains an important part of the fixed income universe, and an active allocation combining both top-down and bottom-up research will be important for investors. 

The fund expects to generate returns from a combination of three sources: (i) interest rate strategies (interest rate duration and yield curve); (ii) credit positioning (sector allocation and name selection); and (iii) active FX management. The investment process comprises top-down fundamental research of each market, as well as bottom-up credit research of each issuer.

The fund is also well diversified, be it the type of issuer (corporate/sovereign), geography or sector. Geographically, the fund has a slight underweight to China against its benchmark, as the fund managers expect an uneven path to recovery in China given recent lukewarm economic data and have expressed caution on the magnitude and effect of broader demand-side stimulus so far. This is in line with our view as we continue to adopt a cautious approach towards China. 

Lastly, within the Asian Fixed Income Fund space, the Manulife Asia Pacific Investment Grade Bond Fund stands out for its strong historical performance and downside risk management relative to its peers. 

Related article - Manulife Asia-Pacific Investment Grade Bond Fund: A strategic way to navigate the Asian IG landscape


JP Morgan Brazil Equity Fund: Look to Brazil for a compelling investment opportunity

Next up, we highlight the JP Morgan Brazil Equity Fund, as we believe there is a compelling case for investing in Brazil, with improving macroeconomic conditions and monetary easing creating a supportive backdrop for equities.

The fund is managed primarily from a fundamental, bottom-up perspective using ideas generated by both the portfolio manager and a team of emerging markets investment professionals. More specifically, the fund focuses on investing in high quality businesses that compound earnings sustainably over the long-term, with in-depth fundamental analysis focusing on the Economics (e.g. sustainable return of capital, cash flow generation), Duration (e.g. industry structure & growth, resilience of the business), and Governance (e.g. shareholder focus, management competence). 

Overall, it runs a concentrated portfolio of approximately 25-50 securities (currently has 37 holdings as of 31 July 2023). The fund also stands out for its strong performance, having managed to outperform its peers, while exhibiting a lower maximum drawdown in the last five years.

Related article - JP Morgan Brazil Equity Fund: Look to Brazil for a compelling investment opportunity


Finally, our top fund pick for the month!

Our top fund pick for the month of September is the Fidelity American Growth Fund A-USD!

The Fidelity American Growth Fund seeks to deliver long-term capital growth by investing in equities of companies that are headquartered or do most of their business in the US. Although the fund has a flexible investment style as it takes into account the prevailing and expected macroeconomic conditions, its core investment approach is to identify companies that are most likely to benefit from secular growth trends.

The fund is also benchmark agnostic and has no restrictions to invest in any comparative market index sector/holdings. As a result of this unconstrained approach, the fund’s exposure may differ substantially from the benchmark. The fund holds a high conviction portfolio of between 60-80 stocks at any time.

Consistent with the current environment of slowing growth and elevated inflation, the fund is defensively positioned, with sizeable overweights to traditionally defensive sectors such as healthcare and consumer staples. Some of the top holdings include the likes of Astrazeneca, Horizon Therapeutics and Johnson & Johnson.

Moreover, over a five-year period, the fund has experienced a lower maximum drawdown as compared to its peers, while also having a stronger performance than its peers. This is a testament to the portfolio managers’ stock picking skills and their quality focused investment philosophy. 

Related article - Fidelity American Growth Fund: Our number one fund pick for exposure to US growth stocks in 2023


Final Thoughts

The US economy continues to remain resilient, powered by the strength of US consumers. Moreover, the labour market also continues to show strength, with US employment having increased the most in eight months in September as hiring rose broadly. Persistent labour market strength could give the Fed ammunition to continue hiking rates, or hold it at elevated levels for a prolonged period of time. Market participants may be finally starting to price in the fact that we are in a new economic regime, where structural forces would keep inflation elevated as compared to the past decade.

Looking across equities, we have a preference for US big tech stocks, given their strong moats, pricing power and global business models. Beyond which, they can also venture into the Japanese equity market, which would continue to benefit from several tailwinds. Last but not least, investors can also consider the Asian Tigers, such as Singapore and South Korea due to more attractive valuations.

Related articles: 

Why these technology stocks are better than the rest

Don’t miss out on our top investment ideas following Japan’s latest policy tweak

The Shifting Geopolitics and The New Asian Tigers


Declaration:

For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) and the analyst who produced this report hold a NIL position in the abovementioned securities.


All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.